Posts From June, 2019

Wavefront-guided PRK shows promise for postkeratoplasty astigmatism

Investigators report outcomes of wavefront-guided photorefractive keratectomy (WG-PRK) for high astigmatism after keratoplasty. Source: AAO

Posted on: Jun 28 2019
By: Saratoga Opthalmology
Leave a response

Week in review: Orion prosthesis, Eyer imager, blindness-free Botswana

This week, Orion’s visual prosthesis gives the Argus II a run for its money, a Brazilian startup presents an affordable and portable ophthalmoscope and an international team eradicates Botswana’s backlog of 6,000 cataract blindness cases. Source: AAO

Posted on: Jun 28 2019
By: Saratoga Opthalmology
Leave a response

Females with IFIS at higher risk for intraoperative complications

This study compared the incidence of intraoperative floppy-iris syndrome (IFIS) in male and female patients undergoing cataract surgery. Source: AAO

Posted on: Jun 27 2019
By: Saratoga Opthalmology
Leave a response

AbbVie to purchase Allergan in strategic $63 billion deal

AbbVie has agreed to acquire Allergan for $63 billion, unlocking key opportunities for growth on both sides of the deal. Source: AAO

Posted on: Jun 26 2019
By: Saratoga Opthalmology
Leave a response

Are patients with IIH at lower risk of developing low-pressure syndrome after lumbar puncture?

Investigators explored the incidence of and risk factors for developing persistent low-pressure syndrome after lumbar puncture (LP) in patients with idiopathic intracranial hypertension (IIH). Source: AAO

Posted on: Jun 26 2019
By: Saratoga Opthalmology
Leave a response

Pembrolizumab shows limited efficacy for metastatic uveal melanoma

This prospective study investigated the efficacy and safety of pembrolizumab as a first-line therapy for metastatic uveal melanoma. Source: AAO

Posted on: Jun 25 2019
By: Saratoga Opthalmology
Leave a response

Conservative rehabilitating strategy offers good outcomes in congenital anophthalmia

Investigators of this multicenter study evaluated long-term outcomes of a progressively enlarging prosthesis with dermis fat grafting for congenital anophthalmia. Source: AAO

Posted on: Jun 24 2019
By: Saratoga Opthalmology
Leave a response

Week in review: Mouse debut, disabled docs, innate confusion

This week, a geneticist unveils the world’s first keratoconus mouse, an ophthalmology researcher with vision loss advocates for an inclusive workforce and new findings challenge the benefits of complement inhibitors in retinal degeneration. Source: AAO

Posted on: Jun 21 2019
By: Saratoga Opthalmology
Leave a response

Vitamin D enhances artificial tear efficacy in patients with dry eye disease

Researchers examined the effectiveness of topical carbomer-based lipid-containing artificial tears (CLAT) and hyaluronate (HU) in patients with dry eye disease. Source: AAO

Posted on: Jun 21 2019
By: Saratoga Opthalmology
Leave a response

Alert: RXQ Compounding issues nationwide recall of sterile products

RXQ Compounding, LLC is voluntarily recalling sterile human and animal products within expiry, including repackaged bevacizumab (Avastin). Source: AAO